EVANSTON, Ill., March 26, 2019 /PRNewswire/ — In a move that strengthens ZS’s existing relationship with Amazon Web Services (AWS), the professional services firm today announced that it has achieved AWS Life Sciences Competency status.
ZS joins a group of companies in the AWS Partner Network that have been recognized for their ability to deliver effective solutions to life sciences customers. The Life Sciences Competency status highlights ZS’s success in building AWS-based solutions for their life sciences customers, including analytics platforms like REVO Analytics™, that help pharmaceutical, biotech and medical device companies make proactive business decisions using critical insights derived from integrated data sources.
To achieve this recognition, companies within the AWS Partner Network must possess deep AWS knowledge and undergo a thorough assessment of the security, performance and reliability of their AWS-based life sciences solutions.
“This AWS competency achievement demonstrates that our customers can be confident that they work with a vetted life sciences partner that uses industry-approved cloud practices,” said Kapil Nayyar, a principal and technology leader at ZS. “It validates that we know how to build solutions specific to life sciences that leverage the best of AWS.”
“The new status ensures that ZS will maintain a close relationship with AWS while constantly learning, improving and adopting the newest best practices and strategies for our cloud-based analytics offerings,” added Dharmendra Sahay, a principal and global leader of integrated analytics solutions at ZS. “It’s a big milestone to work with AWS and open the door to bringing faster data and analytics innovations to our customers.”
About ZS
ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 35 years of experience and 6,000-plus ZSers in 23 offices worldwide, we are passionately committed to helping companies and their customers thrive. To learn more, visit www.zs.com or follow us on Twitter and LinkedIn.
CONTACT: Elizabeth Summers, 312-729-4254, esummers@golin.com
SOURCE ZS
Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK /…
SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular…
BEVERLY HILLS, CALIFORNIA / ACCESSWIRE / November 21, 2024 / Nicole Garrett, CEO of Under…
HUNTINGTON BEACH, Calif., Nov. 21, 2024 /PRNewswire/ -- Beacon Healthcare Systems, is pleased to announce…
Attributes Revenue Growth to Innovative Partnerships, Strong Team, and Unique Value-Based Care Model NEW YORK,…
Automation That Makes a Difference SUNRISE, Fla., Nov. 21, 2024 /PRNewswire/ -- When it comes…